Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher Dott
Lentiviral Haemopoietic Stem/Progenitor Cell Gene Therapy for Treatment of Wiskott-Aldrich Syndrome: Interim Results of a Non-Randomised, Open-Label, Phase 1/2 Clinical Study
The Lancet Haematology
Hematology
Related publications
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients With Wiskott-Aldrich Syndrome
Pediatrics
Child Health
Pediatrics
Perinatology
Wiskott-Aldrich Syndrome
458. Gene Expression and T Cell Receptor Repertoire Analyses in Gammaretroviral Gene Therapy of Wiskott-Aldrich-Syndrome
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Wiskott-Aldrich Syndrome
High-Dose Immunoglobulin Therapy of Wiskott-Aldrich Syndrome
Pediatric Hematology and Oncology
Child Health
Oncology
Pediatrics
Perinatology
Hematology
166. Lentiviral Hematopoietic Stem Cell Gene Therapy for Sjögren-Larsson Syndrome
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: Advances in Biology and Future Directions for Treatment
Immunology and Allergy Clinics of North America
Allergy
Immunology
Wiskott-Aldrich Syndrome Protein Is Required for Regulatory T Cell Homeostasis
Journal of Clinical Investigation
Medicine
